logo
Plus   Neg
Share
Email

Merck, Pfizer Report Positive Top-line Results From Phase III JAVELIN 101 Study

Merck KGaA, and Pfizer Inc. (PFE) announced positive top-line results from the pivotal Phase III JAVELIN Renal 101 study evaluating BAVENCIO (avelumab) in combination with INLYTA (axitinib), compared with SUTENT (sunitinib) as initial therapy for patients with advanced renal cell carcinoma. The company said an independent Data Monitoring Committee has confirmed that the trial showed a statistically significant improvement in progression-free survival by central review for patients treated with the combination whose tumors had programmed death ligand-1?positive expression greater than 1% (primary objective), as well as in the entire study population regardless of PD-L1 tumor expression (secondary objective).

JAVELIN Renal 101 is a global Phase III, multicenter, randomized study investigating the efficacy and safety of BAVENCIO in combination with INLYTA as a first-line treatment option compared with SUTENT monotherapy in 886 patients with advanced renal cell carcinoma across all risk groups.

The company said the JAVELIN Renal 101 will continue as planned to the final analysis for the other primary endpoint of overall survival. The alliance intends to pursue a regulatory submission in the US based on the interim results.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Ford Motor Co. plans to invest $500 million in electric truck maker Rivian, the companies said Wednesday. They will also work together to develop an all-new battery electric vehicle for Ford using Rivian's skateboard platform. Ford's investment comes just months after Rivian revealed two new products, an all-electric pickup and SUV. AT&T Inc. (T) reported first-quarter adjusted earnings per share of $0.86 compared to $0.85, prior year. On average, 23 analysts polled by Thomson Reuters expected the company to report profit per share of $0.86 for the quarter. Analysts' estimates typically exclude special items. Adjusting for amortization,... Shares of Credit Suisse Group AG were gaining around 3 percent in Swiss trading after the banking major reported Wednesday higher profit in its first quarter, despite weak revenues. Looking ahead, the company said it is cautiously optimistic about its prospects for the second quarter of 2019. The company remains focused on increasing its returns over the course of 2019 and beyond.
Follow RTT